NCT05954299

Brief Summary

The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
154mo left

Started Jul 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jul 2023Dec 2038

First Submitted

Initial submission to the registry

July 12, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

July 18, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
10.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2033

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2038

Last Updated

December 7, 2023

Status Verified

December 1, 2023

Enrollment Period

10.5 years

First QC Date

July 12, 2023

Last Update Submit

December 6, 2023

Conditions

Cancer

Keywords

CancerBiobankBiorepository

Outcome Measures

Primary Outcomes (1)

  • Biobank

    Collect quality biospecimens with associated clinical data for research studies related to improving medicine and care to the patient, including cancer screening, treatment, and care.

    10 years

Study Arms (2)

Normal

Participants and donor samples without disease (ex: non-cancer)

Disease state or condition

Participants and donor samples with known disease or condition (ex: cancer)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults age 18 years and older of any gender and demographic group, including both healthy participants and those with disease.

You may qualify if:

  • years of age or older; any gender
  • Able to donate a blood, urine, tissue, and/or other biospecimen sample
  • Able to provide informed consent to participate in the study

You may not qualify if:

  • Minors, under the age of 18 years
  • Individuals who lack the capacity to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vincere Cancer Center

Scottsdale, Arizona, 85260, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Current blood (plasma, red blood cells), urine, and/or tissue; with the opportunity to collect other biospecimens

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Vershalee Shukla, MD

    Vincere Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christine Lau, MD

CONTACT

480-306-5390drlau@vincerecancer.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2023

First Posted

July 20, 2023

Study Start

July 18, 2023

Primary Completion (Estimated)

December 31, 2033

Study Completion (Estimated)

December 31, 2038

Last Updated

December 7, 2023

Record last verified: 2023-12

Locations

US(1)